|
SACM1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.69679999629491E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
5.664100E-02 |
| Stage1-vs-Stage3 |
7.524000E-03 |
| Stage1-vs-Stage4 |
7.790800E-04 |
| Stage2-vs-Stage3 |
1.004840E-03 |
| Stage2-vs-Stage4 |
1.793010E-04 |
| Stage3-vs-Stage4 |
2.246200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.15490000077656E-08 |
| Normal-vs-Asian |
4.21995771660022E-13 |
| Caucasian-vs-AfricanAmerican |
2.879000E-01 |
| Caucasian-vs-Asian |
3.086600E-01 |
| AfricanAmerican-vs-Asian |
7.931600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.353000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
1.98670000000067E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.279600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.482600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.419600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.352000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.595200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.658600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.45700000000615E-05 |
| Classical-VS-Follicular |
3.81790000000271E-05 |
| Classical-VS-Other |
8.082200E-01 |
| Classical-VS-Normal |
1.62814206561279E-12 |
| Tall-VS-Follicular |
7.25060012030099E-10 |
| Tall-VS-Other |
9.494300E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.307220E-01 |
| Follicular-VS-Normal |
1.59179999958958E-07 |
| Other-VS-Normal |
1.164430E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.040800E-03 |
|
|
